These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 2388474)
1. Recombinant interferon-alpha-2C in chronic myelogenous leukaemia: relationship of sensitivity of committed haematopoietic precursor cells in vitro (BFU-E, CFU-GM, CFU-Meg) and clinical response. Geissler D; Gastl G; Aulitzky W; Tilg H; Gaggl S; Konwalinka G; Huber C Leuk Res; 1990; 14(7):629-36. PubMed ID: 2388474 [TBL] [Abstract][Full Text] [Related]
2. Synergistic antiproliferative effect of recombinant interferon-gamma with recombinant interferon-alpha on chronic myelogenous leukemia hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM). Carlo-Stella C; Cazzola M; Ganser A; Bergamaschi G; Pedrazzoli P; Hoelzer D; Ascari E Blood; 1988 Oct; 72(4):1293-9. PubMed ID: 3139105 [TBL] [Abstract][Full Text] [Related]
3. Clonogenic assay is not predictive but reflects therapeutic efficacy of interferons in the treatment of chronic myelogenous leukemia. Wandl UB; Niederle N; Kranzhoff M; Seeber S Int J Cell Cloning; 1992 Sep; 10(5):292-8. PubMed ID: 1453016 [TBL] [Abstract][Full Text] [Related]
4. The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint. Dowding C; Guo AP; Maisin D; Gordon MY; Goldman JM Br J Haematol; 1991 Feb; 77(2):165-71. PubMed ID: 2004017 [TBL] [Abstract][Full Text] [Related]
5. [Effects of recombinant human alpha-2b and gamma interferons on bone marrow megakaryocyte progenitors (CFU-Meg) from patients with chronic myelocytic leukemia]. Tanabe Y; Dan K; Kuriya S; Nomura T Rinsho Ketsueki; 1989 Oct; 30(10):1800-5. PubMed ID: 2512397 [TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia. Carlo-Stella C; Cazzola M; Gasner A; Barosi G; Dezza L; Meloni F; Pedrazzoli P; Hoelzer D; Ascari E Blood; 1987 Oct; 70(4):1014-9. PubMed ID: 3115331 [TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia. Wisniewski D; Strife A; Atzpodien J; Clarkson BD Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231 [TBL] [Abstract][Full Text] [Related]
8. Synergistic antiproliferative effect of interferon alpha and azidothymidine in chronic myelogenous leukemia. Estrov Z; Talpaz M; Chou TC; Kurzrock R; Blake M; Gutterman JU Leukemia; 1991 Feb; 5(2):101-7. PubMed ID: 2020193 [TBL] [Abstract][Full Text] [Related]
9. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units. Gronthos S; To LB; Haylock DN; Juttner CA Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568 [TBL] [Abstract][Full Text] [Related]
10. Effect of recombinant interferons alpha and gamma on human bone marrow-derived megakaryocytic progenitor cells. Ganser A; Carlo-Stella C; Greher J; Völkers B; Hoelzer D Blood; 1987 Oct; 70(4):1173-9. PubMed ID: 3115335 [TBL] [Abstract][Full Text] [Related]
11. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors. Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928 [TBL] [Abstract][Full Text] [Related]
12. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells. Gallicchio VS; Hughes NK; Hulette BC; Noblitt L J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611 [TBL] [Abstract][Full Text] [Related]
13. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433 [TBL] [Abstract][Full Text] [Related]
14. Combination of interferon alpha with either Ara-C or ATRA in vitro reduces the selective action of interferon against CML CFU-GM. Marley SB; Davidson RJ; Goldman JM; Gordon MY Leukemia; 2000 Aug; 14(8):1396-400. PubMed ID: 10942234 [TBL] [Abstract][Full Text] [Related]
15. The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro. Korycka A; Robak T Leuk Lymphoma; 2003 Sep; 44(9):1549-55. PubMed ID: 14565659 [TBL] [Abstract][Full Text] [Related]
16. Treatment of anti-recombinant interferon-alpha 2 antibody positive CML patients with natural interferon-alpha. Wussow PV; Jakschies D; Freund M; Hehlmann R; Brockhaus F; Hochkeppel H; Horisberger M; Deicher H Br J Haematol; 1991 Jun; 78(2):210-6. PubMed ID: 2064959 [TBL] [Abstract][Full Text] [Related]
17. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures. Robak T; Korycka A Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284 [TBL] [Abstract][Full Text] [Related]